# KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution

> **NCT06218979** · PHASE1 · COMPLETED · sponsor: **Helsinki University Central Hospital** · enrollment: 12 (actual)

## Conditions studied

- Psychosis
- Food-drug Interaction

## Interventions

- **DRUG:** Risperidone oral solution

## Key facts

- **NCT ID:** NCT06218979
- **Lead sponsor:** Helsinki University Central Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-08
- **Primary completion:** 2024-03-14
- **Final completion:** 2024-03-14
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218979, "KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral Solution". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06218979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*